-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HdDKojVDUaW8zNayOT1VJfY1yO7ZAl0xsSZ23AOnP5phAWl7m1GVxua2WPDrL1sN KeIOYJry3LCQjHa712shBA== 0001179110-07-010574.txt : 20070518 0001179110-07-010574.hdr.sgml : 20070518 20070518143817 ACCESSION NUMBER: 0001179110-07-010574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070516 FILED AS OF DATE: 20070518 DATE AS OF CHANGE: 20070518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6179952506 MAIL ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PIEN HOWARD H CENTRAL INDEX KEY: 0001187152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 07864329 MAIL ADDRESS: STREET 1: C/O VIROPHARMA INC STREET 2: 405 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 4 1 edgar.xml FORM 4 - X0202 4 2007-05-16 1 0000855654 IMMUNOGEN INC IMGN 0001187152 PIEN HOWARD H 6 CARRIAGE HOUSE COURT CHERRY HILL NJ 08003 0 0 0 1 Former Director Common Stock 2007-05-16 4 M 0 2168 5.03 A 2168 D Deferred Share Unit 0 2007-05-16 4 M 0 2168 0 D Common Stock 2168 2168 D The deferred share units were issued pursuant to the Issuer's 2004 Non-Employee Director Compensation and Deferred Share Unit Plan, as amended, and are convertible into Common Stock on a one-to-one basis. On May 16, 2007, the reporting person resigned from the Board of Directors, and as a result, the vested deferred share units are settled 100% in shares of Common Stock of the Company. The unvested portions of the deferred share units have expired by their terms. The deferred share units are fully vested. The reporting person received 131, 862, and 18 deferred share units on Februray 14, 2007, May 14, 2007, and May 16, 2007, respectively, which vested immediately. The reporting person also received a grant on January 31, 2007 for 13,888 deferred share units, which vested ratably over a three year period in quarterly increments at the end of each quarter, of which 1,157 shares were fully vested upon the reporting person's resignation. /s/ Daniel M. Junius 2007-05-18 -----END PRIVACY-ENHANCED MESSAGE-----